PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-4.78%
Both yoy net incomes decline, with MCHP at -268.31%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
1.32%
Less D&A growth vs. MCHP's 49.84%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
121.43%
Well above MCHP's 166.73% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
41.67%
Less SBC growth vs. MCHP's 244.05%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-274.09%
Negative yoy working capital usage while MCHP is 40.98%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-140.96%
AR is negative yoy while MCHP is 76.53%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-394.44%
Negative yoy inventory while MCHP is 798.92%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-232.20%
Both negative yoy AP, with MCHP at -176.28%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-996.77%
Both reduce yoy usage, with MCHP at -79.11%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
80.84%
Well above MCHP's 59.10%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-42.68%
Negative yoy CFO while MCHP is 10.55%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-15.45%
Both yoy lines negative, with MCHP at -12.28%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Both yoy lines negative, with MCHP at -17956.53%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
43.17%
Less growth in investment purchases vs. MCHP's 99.92%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
46.41%
We have some liquidation growth while MCHP is negative at -71.15%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
126.27%
We have some outflow growth while MCHP is negative at -9.34%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
138.98%
We have mild expansions while MCHP is negative at -245.10%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
75.00%
Debt repayment above 1.5x MCHP's 35.05%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
1441.67%
We slightly raise equity while MCHP is negative at -57.14%. John Neff sees competitor possibly preserving share count or buying back shares.
-15.79%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.